214 related articles for article (PubMed ID: 35006851)
1. Ru(II) Polypyridine Complex-Functionalized Mesoporous Silica Nanoparticles as Photosensitizers for Cancer Targeted Photodynamic Therapy.
Karges J; Díaz-García D; Prashar S; Gómez-Ruiz S; Gasser G
ACS Appl Bio Mater; 2021 May; 4(5):4394-4405. PubMed ID: 35006851
[TBL] [Abstract][Full Text] [Related]
2. A Multi-action and Multi-target Ru
Karges J; Yempala T; Tharaud M; Gibson D; Gasser G
Angew Chem Int Ed Engl; 2020 Apr; 59(18):7069-7075. PubMed ID: 32017379
[TBL] [Abstract][Full Text] [Related]
3. Polymeric Encapsulation of a Ruthenium Polypyridine Complex for Tumor Targeted One- and Two-Photon Photodynamic Therapy.
Karges J; Li J; Zeng L; Chao H; Gasser G
ACS Appl Mater Interfaces; 2020 Dec; 12(49):54433-54444. PubMed ID: 33238711
[TBL] [Abstract][Full Text] [Related]
4. Tumor-Targeting H
Jung E; Lee J; Lee Y; Seon S; Park M; Song C; Lee D
ACS Appl Bio Mater; 2021 May; 4(5):4450-4461. PubMed ID: 35006857
[TBL] [Abstract][Full Text] [Related]
5. Increased Lipophilicity of Halogenated Ruthenium(II) Polypyridyl Complexes Leads to Decreased Phototoxicity in vitro when Used as Photosensitizers for Photodynamic Therapy.
Roy S; Colombo E; Vinck R; Mari C; Rubbiani R; Patra M; Gasser G
Chembiochem; 2020 Oct; 21(20):2966-2973. PubMed ID: 32473056
[TBL] [Abstract][Full Text] [Related]
6. Diatom-like silica-protein nanocomposites for sustained drug delivery of ruthenium polypyridyl complexes.
Shi H; Lou J; Lin S; Wang Y; Hu Y; Zhang P; Liu Y; Zhang Q
J Inorg Biochem; 2021 Aug; 221():111489. PubMed ID: 34000586
[TBL] [Abstract][Full Text] [Related]
7. A novel ruthenium polypyridyl complex for the selective imaging and photodynamic targeting of the Golgi apparatus.
Zhao F; Wang W; Wu W
Dalton Trans; 2021 Mar; 50(10):3536-3541. PubMed ID: 33599670
[TBL] [Abstract][Full Text] [Related]
8. NIR-Absorbing Ru
Lifshits LM; Roque JA; Cole HD; Thummel RP; Cameron CG; McFarland SA
Chembiochem; 2020 Dec; 21(24):3594-3607. PubMed ID: 32761725
[TBL] [Abstract][Full Text] [Related]
9. Ruthenium(II) complexes as bioorthogonal two-photon photosensitizers for tumour-specific photodynamic therapy against triple-negative breast cancer cells.
Lin M; Zou S; Liao X; Chen Y; Luo D; Ji L; Chao H
Chem Commun (Camb); 2021 May; 57(36):4408-4411. PubMed ID: 33949487
[TBL] [Abstract][Full Text] [Related]
10. π-Expansive Heteroleptic Ruthenium(II) Complexes as Reverse Saturable Absorbers and Photosensitizers for Photodynamic Therapy.
Wang L; Yin H; Jabed MA; Hetu M; Wang C; Monro S; Zhu X; Kilina S; McFarland SA; Sun W
Inorg Chem; 2017 Mar; 56(6):3245-3259. PubMed ID: 28263079
[TBL] [Abstract][Full Text] [Related]
11. Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity.
Li S; Zhao J; Wang X; Xu G; Gou S; Zhao Q
Inorg Chem; 2020 Aug; 59(15):11193-11204. PubMed ID: 32702972
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the mechanisms of action and subcellular localization of ruthenium(II)-based photosensitizers.
Mo J; Mai Le NP; Priefer R
Eur J Med Chem; 2021 Dec; 225():113770. PubMed ID: 34403979
[TBL] [Abstract][Full Text] [Related]
13. Polymeric Encapsulation of a Ru(II)-Based Photosensitizer for Folate-Targeted Photodynamic Therapy of Drug Resistant Cancers.
Karges J; Tharaud M; Gasser G
J Med Chem; 2021 Apr; 64(8):4612-4622. PubMed ID: 33818111
[TBL] [Abstract][Full Text] [Related]
14. Ruthenium-Cathepsin Inhibitor Conjugates for Green Light-Activated Photodynamic Therapy and Photochemotherapy.
Denison M; Garcia SP; Ullrich A; Podgorski I; Gibson H; Turro C; Kodanko JJ
Inorg Chem; 2024 Apr; 63(17):7973-7983. PubMed ID: 38616353
[TBL] [Abstract][Full Text] [Related]
15. Polyphosphoester-stabilized cubosomes encapsulating a Ru(II) complex for the photodynamic treatment of lung adenocarcinoma.
Casula L; Elena Giacomazzo G; Conti L; Fornasier M; Manca B; Schlich M; Sinico C; Rheinberger T; Wurm FR; Giorgi C; Murgia S
J Colloid Interface Sci; 2024 Sep; 670():234-245. PubMed ID: 38761576
[TBL] [Abstract][Full Text] [Related]
16. Rational design of type I photosensitizers based on Ru(ii) complexes for effective photodynamic therapy under hypoxia.
Liu X; Li G; Xie M; Guo S; Zhao W; Li F; Liu S; Zhao Q
Dalton Trans; 2020 Aug; 49(32):11192-11200. PubMed ID: 32748922
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic antitumor activity of Ru(ii) complexes of imidazo-phenanthroline conjugated hydroxybenzoic acid as tumor targeting photosensitizers.
Liu ZY; Zhang J; Sun YM; Zhu CF; Lu YN; Wu JZ; Li J; Liu HY; Ye Y
J Mater Chem B; 2020 Jan; 8(3):438-446. PubMed ID: 31833531
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of action of Ru(ii) polypyridyl complexes in living cells upon light irradiation.
Jakubaszek M; Goud B; Ferrari S; Gasser G
Chem Commun (Camb); 2018 Nov; 54(93):13040-13059. PubMed ID: 30398487
[TBL] [Abstract][Full Text] [Related]
19. Catch and Release Photosensitizers: Combining Dual-Action Ruthenium Complexes with Protease Inactivation for Targeting Invasive Cancers.
Arora K; Herroon M; Al-Afyouni MH; Toupin NP; Rohrabaugh TN; Loftus LM; Podgorski I; Turro C; Kodanko JJ
J Am Chem Soc; 2018 Oct; 140(43):14367-14380. PubMed ID: 30278123
[TBL] [Abstract][Full Text] [Related]
20. Photophysical Properties and Photobiological Activities of Ruthenium(II) Complexes Bearing π-Expansive Cyclometalating Ligands with Thienyl Groups.
McCain J; Colón KL; Barrett PC; Monro SMA; Sainuddin T; Roque Iii J; Pinto M; Yin H; Cameron CG; McFarland SA
Inorg Chem; 2019 Aug; 58(16):10778-10790. PubMed ID: 31386351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]